Sorrento Therapeutics Inc (SRNE)

[dia76ca]

This may explain the delay in approval of Covi-Track and Covi-Stix.
"The test uses a proprietary platinum nano-catalyst core (PtNC) which yields up to 100-fold increases in sensitivity over conventional lateral flow colloidal gold assays."
If Sorrento scientists have developed a cheaper or more effective "PROPRIETARY" PtNC this would delay approval! But it would also mean that the company did not get stuck with a huge pile of outdated second-rate test kits! Apparently now they are manufacturing ,testing and stockpiling . a better, far more accurate test! If this is the case they clearly made the correct decision! We'll soon be hearing more IMO! Load up on cheap shares while you can...that's what the institutions are doing!